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Abstract
Background Chlamydia trachomatis is one of the most frequently
reported sexually transmitted infections (STI) in Australia, the UK
and Europe. Yet, rates of screening for STIs remain low, especially
in younger adults.
Objective To assess eﬀectiveness of Chlamydia screening interven-
tions targeting young adults in community-based settings, describe
strategies utilized and assess them according to social marketing
benchmark criteria.
Search strategy A systematic review of relevant literature between
2002 and 2012 in Medline, Web of Knowledge, PubMed, Scopus
and the Cumulative Index to Nursing and Allied Health was
undertaken.
Results Of 18 interventions identiﬁed, quality of evidence was low.
Proportional screening rates varied, ranging from: 30.9 to 62.5% in
educational settings (n = 4), 4.8 to 63% in media settings (n = 6)
and from 5.7 to 44.5% in other settings (n = 7). Assessment against
benchmark criteria found that interventions incorporating social
marketing principles were more likely to achieve positive results, yet
few did this comprehensively. Most demonstrated customer orienta-
tion and addressed barriers to presenting to a clinic for screening.
Only one addressed barriers to presenting for treatment after a posi-
tive result. Promotional messages typically focused on providing
facts and accessing a testing kit. Risk assessment tools appeared to
promote screening among higher risk groups. Few evaluated treat-
ment rates following positive results; therefore, impact of screening
on treatment rates remains unknown.
Discussion Future interventions should consider utilizing a com-
prehensive social marketing approach, using formative research
to increase insight and segmentation and tailoring of screening
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interventions. Easy community access to both screening and treat-
ment should be prioritized.
Introduction
Chlamydia trachomatis (CT) is one of the most
frequently reported sexually transmitted infec-
tions (STI) in Australia,1 the UK2 and in Eur-
ope.3 International prevalence studies highlight
that sexually active adults under the age of
30 years are most at risk of infection.3 If CT is
left untreated, it can lead to serious conditions
such as pelvic inﬂammatory disease and tubal
infertility in females; epididymitis, urethritis
and proctitis in males.4 Reducing the rates of
STIs such as Chlamydia is therefore an impor-
tant public health and social priority across the
world.5
The main risk factors for CT in sexually
active females are as follows: age (<25 years),
inconsistent use of barrier contraceptives (e.g.
condoms), multiple sexual partners, cervical
ectopy and a history of STI or a co-existing
STI.4 Many existing strategies to reduce infec-
tion rates have focused on awareness raising
and behaviour changes relating to condom use.
Because CT is asymptomatic in about 80% of
cases, screening can also provide an eﬀective
method of early detection. In the US and Aus-
tralia, sexual health guidelines recommend
annual CT screening in primary care for all
sexually active females aged between 15 and
25 years, and for sexually active young males
in high risk groups or clinical settings (e.g.
adolescent clinics, correctional facilities, STD
clinics).6–8 However, only a limited number of
countries have taken a systematic approach to
eﬀect Chlamydia control and only 13 of 29
countries in Europe have national guidelines
for screening, diagnosis and management.9
Chlamydia trachomatis screening is non-
invasive and typically involves a urine test or
swab for females, and a urine test for males. In
Australia, CT screening most commonly occurs
through opportunistic screening during a GP
consultation. The 2007/2008 national GP CT
testing rate per 100 sexually active individuals
was 8.0%, although it was considerably higher
in females (12.5%) compared with males
(3.7%).10 In the US, signiﬁcant improvements
in the Chlamydia screening rates have been
achieved through targeted programmes with
eﬀective rates of 45% for insured and 58% for
Medicaid-covered sexually active women aged
16–24 years.11 Whilst there are signiﬁcant vari-
ations internationally in screening and surveil-
lance programmes, what it clear is that
screening rates remain lower in younger adults
and at risk groups than the desired target
rates.9–12
Despite the availability of non-invasive test-
ing methods and highly eﬀective medical treat-
ments, rates of screening for STIs remain low
in younger adults.10 Whilst screening in primary
care settings may be improved by the universal
oﬀer of screening to some patients,13 Low
et al.14 found that there was little evidence to
support opportunistic CT screening across set-
tings for young people aged less than 25 years.
This creates an imperative to develop insight
and evaluate the features of interventions that
can more eﬀectively promote CT screening and
engage this younger demographic.
Previous sexual health research15 and current
government sexual health policies in countries
such as the UK16 have highlighted that gaining
the consumer (or participant) perspective is cen-
tral to understanding how to increase the utiliza-
tion of sexual health screening programmes.
This mirrors a wider recognition of the impor-
tance of consumer orientation in public health
service delivery.16,17 Social marketing is a strate-
gic framework that has successfully utilized a
consumer-centred approach to support attitudi-
nal and behaviour change at a group or commu-
nity level across numerous health issues.18,19
Therefore, it may have utility in facilitating
access and use of Chlamydia screening among
young people in the community.
This article presents the ﬁndings from a sys-
tematic literature review that examines current
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evidence regarding the nature and eﬀectiveness
of consumer approaches to promote opportu-
nistic CT screening within a range of com-
munity settings to engage young people
(<30 years). Whilst a recent review investigated
home-based Chlamydia and gonorrhoea screen-
ing strategies and outcomes,20 this study is the
ﬁrst to evaluate the approaches within a variety
of ‘non-clinical’ community settings. Further-
more, although current CT interventions use a
variety of frameworks and approaches, social
marketing has been suggested as a particularly
relevant and promising approach to sexual
health programmes. The present systematic
review also assesses included interventions
against recognized social marketing benchmark
criteria.21 Whilst it is important to acknowledge
that included interventions may not have been
planned using the social marketing framework,
this assessment can help identify strengths and
weaknesses in current approaches and identify
useful strategies for future interventions. This
approach has been used in previous reviews on
the eﬀectiveness of behaviour change interven-
tions for other health issues.19,22
Social marketing is a systematic framework
that uses marketing principles to promote
socially beneﬁcial behaviour change.23 It is
distinctive from other approaches as it is con-
sumer orientated and facilitates change by
enhancing the beneﬁts associated with the
behaviour and minimizing the costs.23 Well-
designed social marketing programmes have
been eﬀective in promoting health behaviour
change in relation to substance misuse, food
and nutrition and physical activity;19,22 and
other screening behaviours, for example, colo-
rectal cancer.24 Given the eﬀectiveness of
social marketing in other health behaviours,
it is appropriate to investigate the utility of
its principles to promote CT screening. Whilst
the majority of interventions in the systematic
review were not conceptualized according to
social marketing principles, the social marketing
benchmarking criteria provide insight into the
relative strengths and weaknesses of existing
interventions from this perspective. Further-
more, this allows for recommendations for the
development of future CT screening that could
utilize social marketing as a framework.
Method
A systematic literature search using the data-
bases Medline, Web of Knowledge, PubMed,
Scopus and the Cumulative Index to Nursing
and Allied Health was conducted to identify
published behavioural interventions to increase
Chlamydia screening. The following terms were
used to search for academic peer-reviewed
published articles published in English from
January 2002 to June 2012: ‘Chlamydia AND
(screen or screening or intervention* or social
marketing or program* or campaign)’. Titles
and abstracts were screened by two reviewers
to identify potentially relevant articles. Refer-
ence lists of identiﬁed articles were also
searched to identify any additional relevant
papers. Full-text articles were read independently
by two of the authors to ensure consensus was
reached on the ﬁnal articles to be included. Stud-
ies were included if they measured CT screening
behaviour (not just knowledge or beliefs), tar-
geted CT screening onlya, targeted people under
30 years of age and were implemented in non-
clinical settings. Whilst it is noted that national
population screening rates are often provided for
a more limited age range (15–24 years), many of
the relevant research studies included people
aged from 15 to 30 years and were included to
ensure all relevant literature was reviewed.
Exclusion criteria were as follows: educational
or awareness raising programmes with no behav-
iour change objectives, poster presentations and
review articles, and non-academic and unpub-
lished grey literature. Whilst included studies
may have also aimed to change knowledge or
beliefs, the focus of this study was on reviewing
interventions in relation to their eﬀectiveness in
promoting CT screening and follow-up in at-risk
segments, and investigating the settings and
strategies used. The three primary behavioural
aInterventions targeting Chlamydia in addition to other
health issues were excluded, as Chlamydia is largely asymp-
tomatic and therefore the focus of interventions is distinct.
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outcome measures reported included number of
tests (as a proportion of those exposed to the
intervention), positivity rate (as a proportion of
those tested) and treatment rates were reported
(as a proportion of those who tested positive).
Behaviours such as ‘logging on to a website’ or
‘downloading’ information or forms were also
noted if reported. Finally, consistent with the
objectives of the systematic review, an overall con-
sensus about the interventions was reached by two
of the reviewers. All interventions were judged
against three primary behavioural outcomes: the
proportional screening rates, the number of posi-
tive tests and the ability of the intervention to
support treatment in participants who tested
positive (also reported as a proportional rate).
Interventions included in the systematic review
were also assessed against the UK National
Social Marketing Centre’s Social Marketing
National Benchmark Criteria.16 The benchmark
criteria present eight integrated elements that
should be featured in a comprehensive social
marketing intervention (see Table 1). Interven-
tions were also evaluated for quality on the basis
of study design and outcome measures using the
GRADE protocol.25 Coders met periodically
during the process, and intercoder reliability
checks were conducted on the entire sample
between the two researchers. The coeﬃcient of
agreement [the total number of agreements
(n = 17) divided by the total number of coding
decisions (n = 20)] was 85%, and a third
researcher resolved any disagreements.
Results
The search strategy yielded a total of 10 593
references (see Fig. 1). After excluding dupli-
cates and papers not fulﬁlling the inclusion cri-
teria, 30 full-text articles were reviewed with a
further seven studies identiﬁed from references
list searches. Of these 37 articles, 17 papers in
Table 1 Outline of the social marketing national benchmark criteria (French, Blair-Stevens, 2005)
Benchmark Description
Behaviour The intervention needs to have a clear focus on a speciﬁc behaviour (e.g. CT screening), not merely
psychological factors such as attitudes or intentions. There needs to be a detailed understanding
of the ‘problem’ and ‘desired’ behaviours.
Customer
Orientation
The intervention should be informed by a broad and robust understanding of the customer. Formative
research and pre-testing are important in identifying consumer characteristics and needs.
Theory Interventions should be informed by relevant behavioural theories that are used to understand the
target behaviour (e.g. beliefs, barriers).
Insight Formative research should lead to an insight into the factors that inﬂuence behaviour (e.g.
psychological and physical barriers). This insight is important for developing the intervention,
and in particular addressing issues surrounding exchange and competition.
Exchange This involves understanding the beneﬁts and costs to the individual of behaviour change and
maintenance. In particular, there is a need for the intervention to maximize the beneﬁts and
minimize the costs to make the behaviour change attractive to the individual.
Competition This element recognizes that lots of different factors compete for the individual’s time and
attention; these can impede behaviour change. The intervention therefore needs to minimize
the impact of competition, which could be achieved through maximizing the value of the
exchange. Development of strategies that aim to minimize the potential impact of the competition.
Segmentation The target ‘audience’ is not homogeneous and may have different attitudes, beliefs and
barriers which have the potential to inﬂuence intervention success. As a result, it is important
to identify subpopulations (i.e. segments) that share similar geographic, psychological and
behavioural characteristics. Interventions should be tailored according to the distinct
characteristics of these segments.
Methods Mix This ﬁnal element emphasizes the importance of using a range of different methods to promote
behaviour change. That is, interventions cannot merely rely on education and also need
to incorporate elements of the marketing mix (i.e. product, place, promotion and price).
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primary care or hospital settings were excluded.
However, two programmes which oﬀered a
choice of clinic or community-based screening
were included.26,27 A ﬁnal total of 20 papers
were included in the systematic review.
From the 20 papers, 18 interventions were
reported on (two papers from Gaydos et al.28,29
were both reporting results from the same inter-
vention, and van Bergen et al.30 and van den
Broek et al.31 were also two papers reporting on
the same intervention). The interventions were
conducted in the following settings: pharma-
cies,32–35 high schools,36,37 universities,38,39 Inter-
net-based28,29,40 and media-based campaigns.26,27
However, these are diﬃcult to strictly categorize
as many interventions were conducted across
settings. Intervention designs included one
RCT,41 two quasi-experimental studies,39,42 two
pre- and post (no control)-evaluations
designs31,34,43 and six cross-sectional/post-test
designs.27,32,33,38,44,45 The remaining eight inter-
ventions did not explicate study designs, but
could be described as observational or descrip-
tive designs.28,29,35–37,40,46,47 Most targeted
adolescents and young adults (14–29 years)
although some only speciﬁed an adult target
group, or no target group (as they were obser-
vational studies). Five had speciﬁc gender tar-
Full manuscript N = 37
including 7 identified from reference 
lists
Excluded N = 7309
Disease not relevant
Not screening
Review articles
Poster Presentations
Titles and abstracts screened 
N = 7345 
Excluded: Duplicates
N = 3248
References identified
N = 10,593
Excluded N = 17
Interventions in primary care or 
hospital setting
Papers set in community 
pharmacies
N = 4
Papers set in educational 
settings
N = 4
Papers set in 
populations/community 
settings N = 12
Figure 1 Flowchart.
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get groups, three females only28,35,36 and two
males only.40,45 Audiences were also targeted
within particular settings or groups, for exam-
ple. pharmacy customers,32,33,35 music festival
attendees,44 high-school students36,37 and men
who were members of a private health fund45
or those living within speciﬁc geographic
regions. Three interventions targeted disadvan-
taged communities one multicultural neighbour-
hood,34 one disadvantaged school37 and one
rural high school.36 Three interventions also
targeted people performing other non-STI-
related health behaviours, for example those
attending a health clinic38 and young women
buying oral contraceptives from a pharmacy
(Table 2).34,35
Effectiveness of interventions on screening,
positivity rates and treatment rates
In relation to uptake of CT screening, nine were
judged as having a high impact,28,29,32,36–42
three a moderate impact27,34,35,44 and ﬁve a low
impact on screening rates.30,31,33,45–47 Three of
the four interventions that achieved a higher
positivity rate included a formal risk assess-
ment for participants as part of their strategy
to promote testing in higher risk groups.27,40,43
None of the interventions with lower rates of
positive tests included such a formal risk
assessment.
Of the 11 interventions where participants
had a positive test result, only four reported
the number of those who accessed treat-
ment.32,35,39,43 This ranged from 47.1 to 91%
of those who had tested positive for Chlamydia
following participation in the intervention.
Social marketing benchmark criteria
Each of the included interventions was evalu-
ated against the social marketing benchmark
criteria (see Table 3). Of the nine interventions
found to have a positive impact, two36,39 met
seven of the eight social marketing benchmark
criteria, but did not report the theory utilized,
and one met six criteria, but did not report the
use of theory or segmentation.29 Another inter-
vention met ﬁve benchmark criteria omitting
customer orientation, theory and competition,43
one met ﬁve criteria but did not report against
customer orientation, theory or insight,37 one
met ﬁve criteria but did not report against the-
ory, insight or exchange38 and one met ﬁve crite-
ria: but did report use of theory, competition
and segmentation.32 Finally, one intervention
met four of the eight benchmarks, whilst not
reporting against theory, insight, exchange and
segmentation.40
Of the interventions that had low-modest
impact, one met seven criteria but did not report
use of theory,35 one met six criteria but did not
report the use of theory or competition44 and
one met six criteria but not competition and seg-
mentation.46 Two of these interventions met
four criteria but did not report customer orienta-
tion, theory, competition or segmentation,45,47
and another met four criteria but did not feature
the use of theory, insight, competition or
segmentation.30
Behaviour
All 20 interventions had a speciﬁc behaviour
goal of increasing participation in Chlamydia
screening. Four interventions promoted oppor-
tunistic on-site CT testing in clinics, in educa-
tional settings, in two universities38,39 and in
two high schools.36,37 Another intervention
randomized participants to on-site testing at a
youth centre or community health centre as
part of a clinical trial42. All of these interven-
tions promoted urine CT tests, except Aldeen
et al.38 who oﬀered a vaginal swab. Two inter-
ventions promoted screening at community
health clinics and/or with a GP.26,27
Fourteen interventions promoted home CT
screening behaviours, via purchased32 or free
CT kits from community pharmacies,33–35 at a
music festival,44 a youth centre participating in
a clinical trial,42 direct mail to participants41,45
or online.28–31,40,46,47 Fifteen interventions pro-
moted the use of urine CT tests kits. Three
promoted use of vaginal swabs,28,29,41,42 while
one43 provided urine tests for men and vaginal
swab tests for women. Only one intervention
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Table 2 Summary of articles Chlamydia trachomatis (CT) screening interventions in community settings
Study Description Outcomes
Aldeen et al. (2010)
UK38
Target: University students Overall: Mixed results
CT tests: Urine(males),
Vaginal swab (females)
Outcomes measures*
Number of tests: 88 (35.2%)
Positivity: 4.2%
Treatment: N/A
Setting: University clinic
Design: Cross-sectional
Alicea-Alvarez
et al. (2011)
US36
Target: Adolescent females Overall: Mixed Results
Outcomes measures
Number of tests: 51/165 (30.9%)
Positivity: N/A
Treatment: N/A
CT tests: Urine test
Setting: High-school clinic
Design: Cross-sectional
Andersen et al.
(2002)
Denmark41
Target: Males and females
aged 21–23 years
Overall: Mixed results
Outcome measures
Number of tests: 771 (38.6%) and 659 (33%)
Positivity: 42 (6.5%) and 42 (8%)
Treatment: N/A
CT tests: Home vaginal swab
Setting: Country region
Design: Randomized control trial
Anderson et al.
(2011)
UK32
Target: Adults Overall: Positive effect
Outcome measures:
Number of tests: 14 378 (2 years)
Positivity: 1131/14 378 (0.8%)
Treatment: 533/1131 (47.1%)
CT tests: Home urine test
Setting: Pharmacy
Design: Cross-sectional
Barry et al. (2008)
US37
Target: Adolescents (male
and female)
Overall: Mixed results
Outcomes measures
Number of tests: 537/967 (63%)
Positivity: 1.3% (identiﬁed at risk)
Treatment: N/A
CT tests: Urine test
Setting: High-school clinic,
disadvantaged area
Design: Cross-sectional
Brabin et al. (2009)
UK35
Target: Females <25 years
requesting contraception
Overall: Mixed results
Outcome measures
Number of tests: 264/1348 (17.6%)
Positivity: 24/264 (9.1%)
Treatment: 22/24 (91.7%)
CT tests: Home Urine Test
Setting: Pharmacy
Design: Quasi-experimental
Chai et al. (2010)
US40
Target: Males >14 Overall: Positive results
Outcomes measures
Number of tests: 512 (31%)
Positivity: 64/501 (13%)
Treatment: N/A
CT tests: Home urine test
Setting: Internet based
Design: Cross-sectional
Chen et al. (2007)
Australia26
Target: 16–29 years Overall: Mixed results
Outcomes measures
Number of tests: 2842 (men) and 6049
(women) Not reported
Positivity: 1.9% (men) and 4.3% women
Treatment: N/A
CT tests: Existing services
Setting: Media campaign.
Design: Cross-sectional
Emmerton et al.
(2011)
Australia33
Target: Adults Overall: Mixed Results
Outcomes measures
Number of tests: 18/156 (12%)
Positivity: N/A
Treatment: N/A
CT Tests: Home urine test
Setting: Pharmacy
Design: Cross-sectional
Gaydos et al.
(2006, 2009)
US28,29
Target: Females >14 years Overall: Positive effect
Outcomes measures
Number of tests: 1254† (32%) (Wave 1)
3774† (32.4%) (Wave 2)
CT Test: Home vaginal swab
Setting: Regional, Internet
Campaign
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Table 2. Continued
Study Description Outcomes
Positivity: N/A
Treatment: N/A
Design: Cross-sectional/
Observational
Jones et al. (2007)
South Africa42
Target: Women – aged 14–25 years Overall: Positive effect
Outcomes measures
CT tests: Clinic 131† (42%);
Home 143† (47%)
Positivity: 22%
Treatment: N/A
CT Test: Clinic or home vaginal swab
Setting (s): Mail and clinic
Design: Quasi-experimental
Kwan et al. (2012)
Australia43
Target: Not speciﬁed Overall: Positive effect
Outcomes measures
CT Request form downloaded: 675
CT Tests: 378/675 (56%)
Positivity: 378† (18%)
Treatment: 50%† within 7 days
CT Tests: Urine test (males),
vaginal swab (females)
Setting: Website
Online intervention to
promote self-risk assessment,
testing and referral for
treatment (n = 675)
Novak and
Karlsson (2006)
Sweden47
Target: Not speciﬁed Overall: Low-moderate results
Outcomes measures
19 518 website visits
CT Test Requests: 1405/256, 886 (0.4%)
CT Tests: 906/1405 (62.5%)
Positivity: N/A
Treatment: N/A
CT Test: Home Urine Test
Setting: Website
Design: Cross-sectional
Oh et al. (2002)
US46
Target: Males and Females
15–25 years
Overall: Low-moderate results
Outcomes measures
Hotline use: 642 calls
(Average 99 calls/week vs. 9 calls
per week pre-campaign)
CT tests: 31/642 callers (4.8%)
Positivity: N/A
Treatment: N/A
CT Test: Home Urine Test
Setting: Media Campaign
Design: Cross-sectional
Sacks-Davis et al.
(2010)
Australia44
Target: males and females
aged 16–29 years
Overall: Low-moderate results
Outcomes measures
Number of tests: 67/313 (21%)
Positivity: 1/67 (1%)
Treatment: N/A
CT Test: Home-Urine Test (males);
Home – vaginal swab (females)
Setting: Music festival
Design: Cross sectional study
Scholes et al. (2007)
US45
Target: Men Overall: Low results
Outcomes measures
CT Tests: 5.7%
Positivity: N/A
Treatment: N/A
CT Test: Home Urine Test
Setting: Health fund members
Design: RCT
van Bergen et al.
(2004)
Netherlands34
Target: Females (15–29 years)
collecting contraceptives
Overall: Moderate results
Outcomes measures
Number of tests: 73/270 (27%)
Positivity: 4.2%
Treatment: N/A
CT Test: Home Urine Test
Setting: Pharmacy, Low income area
Design: Cross-sectional
Vaughan et al.
(2010)
Ireland39
Target: 18–29 years Overall: Positive effect
Outcomes measures
Number of tests: 592/1249 (47.5%)
Positivity: 21/358 (3.9%)
Treatment: 18/21 (87%)
CT Test: Clinic Urine Test
Setting: University
Design: Quasi-experimental
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(reported in two papers) provided users a
choice of vaginal or urine testing.30,31
Customer orientation
Only eight interventions reported the conduct
of primary formative research with the target
audience prior to design and implementation.
This included the use of interviews,33 surveys,44
focus groups,26,28,29,46 pre-testing of campaign
messages26,46 and the conduct of pilot interven-
tions.30–32,35,46 Three others interventions dem-
onstrated limited customer orientation during
and after the intervention via the conduct of
process and audience impact evalua-
tion.26,39,42,44,46 Only one study reported on
data collected from those who both partici-
pated in screening and those who did not.28,29
The remaining interventions reported very lim-
ited customer orientation via their reference to
secondary sources to inform design.36–38,40
Theory
According to this benchmark, interventions
should be informed by relevant behavioural
theories that are used to understand the target
behaviour. Only two included interventions
identiﬁed the use of theory. Sacks-Davis
et al.44 referred to the Health Belief Model and
Oh et al.46 to the Theory of Reasoned Action
and the Media Practice Model as theoretical
frameworks. However, neither explicitly stated
how these theories were applied to the design,
conduct or evaluation of the interventions.
Insight
Those interventions that conducted formative
research highlighted the following insights into
their target audiences: diﬃculty accessing issues
to medical settings and the appeal testing in
non-medical environments,32,39 the attitudes of
clientele attending music festivals44 and barriers
to staﬀ delivering CT screening in the phar-
macy setting.33
Other interventions referenced only existing
research to provide insight into target audience
barriers and motivators to undertaking the CT
screening. For example, barriers to testing in
young people, such as costs, clinic waiting
times, inconvenience, fear of medical proce-
dure, stigma, and lack of privacy, stigma,
embarrassment and a lack of routine testing by
GPs27–29 and the need to correct misinforma-
tion about CT.46 Motivators for seeking CT
testing such as exposure of adolescents to
information on CT and a young person’s sense
of self and lived experience were also identiﬁed
in a single study.46
Exchange
All of the reviewed studies sought to mini-
mize costs associated with behaviour change
to make it more attractive to the individual.
Table 2. Continued
Study Description Outcomes
van Bergen et al. (2010)‡30
van den Broek
et al. (2010)
Netherlands‡31
Target: 16–29 Overall: Low results
Outcomes measures
CT Tests: 73/270 (27%)
Positivity: 4.2%
Treatment: N/A
CT Test: Home-Urine Test (males);
Home – vaginal swab (females)
Setting: Website
Design: Cross-sectional
Wilkins and Mak (2007)
Australia27
Target: 15–24 years Overall: Moderate – positive effect
Outcomes measures:
CT Tests: females (21%†); males (29%†)
Positivity: Females (12%†); males (4%†)
Treatment: N/A
Clinic urine test (males),
clinic vaginal swab (females)
Setting: Media
Design: Cross-sectional
*Studies may have also reported changes in knowledge or attitudes etc; however, only behavioural outcomes are reported.
†Only percentages reported.
‡For interventions with more than one publication, the most recent results are reported.
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Table 3 Community base Chlamydia trachomatis (CT) interventions evaluated utilizing social marketing benchmark criteria
Study Coding against benchmark criteria
Aldeen et al. (2010)
UK38
1. Target behaviour: Clinic urine test (males), clinic vaginal swab (females)
2. Customer Orientation: Literature search conducted on CT screening studies.
3. Theory: N/A
4. Insight: N/A
5. Exchange: N/A
6. Competition: Addressed barriers of access to screening by utilizing an alternative setting
7. Segmentation: 18 + , sexually active, attendees of university health centre.
8. Methods Mix: Promotion –posters, ﬂyers, information sheets; Place – convenience
and accessibility.
Alicea-Alvarez et al. (2011)
US36
1. Target behaviour: Clinic urine test
2. Customer Orientation: Literature review of similar CT screening programmes in high schools.
3. Theory: N/A
4. Insight: Analysis and review of literature to support intervention and understand
barriers and motivators
5. Exchange: Gift voucher incentives.
6. Competition: Soft drinks and water provided to aid participants to give a sample.
Students excused from classes to provide samples, screening process designed
to maximize conﬁdentiality and privacy.
7. Segmentation: Materials designed for adolescent girls in rural setting
8. Methods Mix: Promotion – education including PowerPoint presentation delivered
by research team to students in class, Q&A session, incentives; Place – convenience
Anderson et al. (2002)
Denmark41
1. Target behaviour: Home vaginal swab
2. Customer Orientation: N/A
3. Theory: N/A
4. Insight: N/A
5. Exchange: 6. Competition:
6. Segmentation: N/A
7. Methods Mix: Leaﬂets, home sampling kit.
Anderson et al. (2011)
UK32
1. Target behaviour: Home urine test
2. Customer Orientation: Informed by pilot intervention data
3. Theory: N/A
4. Insight: From pilot data – understanding issues of access; male utilization
of this mode of testing
5. Exchange: Oering beneﬁt (ﬁnding out if positive) by reducing costs (i.e. barriers)
to testing
6. Competition: N/A
7. Segmentation: N/A
8. Methods Mix: Trained pharmacist consultations, email/text/phone results service,
information booklets.
Barry et al. (2008)
US37
1. Target behaviour: Clinic urine test
2. Customer Orientation: N/A
3. Theory: N/A
4. Insight: N/A
5. Exchange: Prizes (from $10-$80) issued randomly, treatment services oered
at times and locations convenient to students.
6. Competition: Addressed barriers of access, conﬁdentiality, privacy
7. Segmentation: Non-sexually active students were discouraged from testing.
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Table 3. Continued
Study Coding against benchmark criteria
8. Methods Mix: Promotion – education: 10 minute presentation on CT and screening,
incentives; Place – convenience: Price – parents not informed of the results.
Steering committee (nurses, teachers, students, parents) for intervention. STD factsheets.
Brabin et al. (2009)
UK35
1. Target behaviour: Home urine test
2. Customer Orientation: Informed by pilot intervention data
3. Theory: N/A
4. Insight: From pilot data – understanding of whether screening was acceptable
to pharmacies
5. Exchange: Oering beneﬁt (ﬁnding out if positive) by reducing costs (i.e. barriers)
to testing
6. Competition: Addressed barriers of access, cost and convenience.
7. Segmentation: Females >25 requesting Emergency Hormonal Contraception at pharmacies
8. Methods Mix: Trained pharmacist consultation, home kit and free postage,
fact sheet, information on local treatment services
Chai et al. (2010)
US40
1. Target behaviour: Visit website and home urine test
2. Customer Orientation: Some scoping of literature – identiﬁed lack of research in internet
based interventions targeting men
3. Theory: N/A
4. Insight: N/A
5. Exchange: N/A
6. Competition: Address barriers of access to screening such as transport, cost,
no health insurance, conﬁdentiality
7. Segmentation:
8. Methods Mix: Free kits, testing and treatment, information booklet, ﬂyers, radio,
campaign website: www.iwantthekit.org. sampling kit.
Chen et al. (2007)
Australia26
1. Target behaviour: CT test using existing services
2. Customer Orientation: Formative – focus groups, pre-testing of campaign messages.
Qualitative evaluation via intercept + survey
3. Theory: N/A
4. Insight: N/A
5. Exchange: N/A
6. Competition: N/A
7. Segmentation: Gender speciﬁc messages
8. Methods Mix: Promotion – Print Ads, Take-Away Cards in bars, clubs,
hotels and tertiary institutions, newspapers, magazines, local press, transport, website.
Emmerton et al. (2011)
Australia33
1. Target behaviour: Home urine test
2. Customer Orientation: Interviews with pharmacy sta.
3. Theory: N/A
4. Insight: Commitment issues relating to workload, issues with sta member t
aking responsibility for driving the distribution of specimen collection kits,
sta discomfort at verbally introducing the screening concept.
5. Exchange: N/A
6. Competition: N/A
7. Segmentation: N/A
8. Methods Mix: Trained pharmacy sta, Self-collection postal kit, text/phone
results service, in-store posters and leaﬂets.
Gaydos et al. (2006, 2009)
US28,29
1. Target behaviour: Visit website and home vaginal swab
2. Customer Orientation: Formative – focus groups to inform internet delivery.
Quantitative results from those who sent kit in (via survey) and those who didn’t.
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Table 3. Continued
Study Coding against benchmark criteria
3. Theory: N/A
4. Insight: Address barriers to access and screening such as fear of pelvic exam,
embarrassment, cost, parental involvement/privacy and stigma. Understanding
of women and the internet for getting info on STDs.
5. Exchange: Encouraged women to adopt behaviour (CT testing) by oering beneﬁt
(test result) and reducing barriers (collection of urine in own home)
6. Competition: Address internal (fear of pelvic exam, embarrassment) and external
(time to visit clinic, costs, parental involvement) competition by providing alternatives
to access (home based kit) and screening test (self test).
7. Segmentation: N/A
8. Methods Mix: Promotion – ﬂyers, radio, newspapers, magazines, website: iwantthekit.org
Jones et al. (2007)
South Africa42
1. Target behaviour: Clinic or home vaginal swab
2. Customer Orientation: Interviews conducted with participants on enrolment
regarding their socio-demographic characteristics and their sexual history. Interviews
were conducted with participants post intervention on the feasibility and acceptability
of the intervention.
3. Theory: N/A
4. Insight: N/A
5. Exchange: Free screening equipment, educational materials and treatment services
in exchange for performing screening tests.
6. Competition: Educational materials and provision of free testing kits, and free
screening and treatment services attempted to overcome ﬁnancial barriers to
CT screening among a poor population.
7. Segmentation: All participants were interviewed at enrolment on socio-demographic
and sexual history.
8. Methods Mix: General information sessions on STs and study description sessions
held at four community based youth groups and two public health clinics. Home kits
contained instruction booklet, educational materials testing kit (product), and
a toll-free phone-line number. Women in the clinic received a bag containing condoms,
educational materials and a clinic appointment card.
Kwan et al. (2012)
Australia43
1. Target behaviours: Urine test (males), vaginal swab (females)
2. Customer Orientation: N/A
3. Theory: N/A
4. Insight: Barriers to testing in young people – costs, clinic waiting times, inconvenience,
fear of medical procedure, stigma, and lack of privacy. Also no routine testing by GPs
(especially men and young people in rural areas). Low uptake of home tests – fear?
Suspicion? embarrassment
5. Exchange: Home based tests overcome some barriers
6. Competition: N/A
7. Segmentation: Community
8. Methods Mix: “Get the facts’ Website – Online risk self-assessment, Mass media
(print, radio, convenience ads in pubs, clubs, cafes and unis); Printout referral
to Path West Labs; Advice about the test and what will happen, and that it is covered
by Medicare; Promotion of the Testing services and locations (Path West Labs – >70
throughout WA); advice service for those <16 years); choice to attend DOHA funded
Sexual Health service or a medical practitioner for treatment
Novak and Karlsson (2005)
Sweden47
1. Target behaviour (s): Log on to website; order home urine test; Test; Use test; return
test; log on to check results; visit physician if possible; participate in counselling
if oered (social work); consent to partner tracing
2. Customer Orientation: N/A
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Table 3. Continued
Study Coding against benchmark criteria
3. Theory: N/A
4. Insight: Home sampling is easy – but many kits are never used (even when provided
and posted free). Need to include men and women in promotion to eective reduce
screening rates
5. Exchange: Secure website; free kits; easy access to results; only need to present
to physician if positive result; print out of referral to take to physician; oered
counselling and partner tracing if positive by a trained social worker (support)
6. Competition: N/A
7. Segmentation: N/A
8. Methods Mix: Provision of home testing kit (Mail out);
Related Chlamydia Website (secure online reporting; interpretation of results;
print out of physical referral if test was positive; printed referral from website
for positive results;
provision of counselling (social work) intervention on basis of physician letter
to indicate treatment had been sought;
reminder emails and phone calls if no letter feedback from physician to indicate
treatment had been access within 4 weeks (if results +ve) message only if test
was negative
Marketing strategy (press conference; posters at youth centres and schools;
banner ad on popular ‘chat’ website; video commercial at local sporting arena
Oh et al. (2002)
US46
1. Target behaviour: Call CT hotline or Options Phone Line; home urine test
2. Customer Orientation: Pre – formative campaign and focus groups to develop
intervention. Pilot tested materials prior to intervention. During – quantitative data;
3. Theory: Theory of Reasoned Action & Media Practice Model
4. Insight: Identify and address barriers – e.g. correct misinformation about CT,
privacy issues, access. Motivators (use of TV as source of information for
adolescents) sense of self and lived experience
5. Exchange: Hard talk about STIs so get the facts from the phone line/brochure; serious
consequences if not treated (and asymptomatic); important to call; oer of 5 testing sites
in local area
6. Competition: N/A
7. Segmentation: N/A
8. Methods Mix: Mail out (brochure); TV and radio campaign; Pre-recorded Check-it-Out
Chlamydia Hotline; A staed Chlamydia Options information line; a free Chlamydia
test (LCR) (clinic-based);
Sacks-Davis et al. (2010)
Australia44
1. Target behaviour: Home urine test (males), home vaginal swab (females)
2. Customer Orientation: Cross-Sectional Survey. Process and Impact Evaluation
3. Theory: Note HBM but unclear if utilized in design of study
4. Insight: Address barrier of access, ease of testing. Tried to understand cliental using
this venue for intervention.
5. Exchange: Incentives were oered to participate (cold drinks, lollipops, prize draw for MP3
player and CD vouchers).
6. Competition: N/A
7. Segmentation: Targeted young people aged 18–29 who attended a music festival and
are statistically more likely to be sexually active and at risk of STDs.
8. Methods Mix: Market stall in festival site, sta on site to recruit participants,
use of incentives (cold drinks, lollipops, prize draw for MP3 player and CD vouchers).
Scholes et al. (2007)
US45
1. Target behaviour: Home urine test
2. Customer Orientation: N/A
3. Theory: N/A
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Table 3. Continued
Study Coding against benchmark criteria
4. Insight: Young men don’t often attend health care settings and need for
interventions to target male to lower infection (not customer need though)
5. Exchange: Oering beneﬁt (ﬁnding out if positive) and reducing costs to testing;
address barriers via mail out strategy – time, logistics, discomfort
6. Competition: N/A
7. Segmentation: N/A
8. Methods Mix: Letter + test request form; Letter + mail back kit)
van Bergen et al. (2004)
Netherlands34
1. Target behaviour: Home urine test
2. Customer Orientation: N/A
3. Theory: N/A
4. Insight: N/A
5. Exchange: N/A
6. Competition: N/A
7. Segmentation: low income females <30 years old and using contraceptives
8. Methods Mix: Information leaﬂet, and a screening kit
Vaughan et al. (2010)
Ireland30
1. Target behaviour: Clinic urine test
2. Customer Orientation: Literature review to identify issues and barriers to screening.
Process evaluation (seven [six female, one male] participant interviews conducted
post intervention).
3. Theory: N/A
4. Insight: Identiﬁed that young people desired a hassle free, non-clinical setting
screening process.
5. Exchange: Provided participants with a free, anonymous, easy to access, and
private screening process. Volunteers oered €25 vouchers as incentives. Oered
participants a sense of relief and peace of mind by taking a test.
6. Competition: Addressed barrier of screening in clinical settings by oering an
alternative non clinical setting. Increased self-eﬃcacy for testing by reducing
embarrassment for taking a test by creating a normalized – everyone is doing it,
atmosphere.
7. Segmentation: Speciﬁcally targeted students aged 18–29 who are most at risk of CT.
8. Methods Mix: Programme was part of an overall Sexual Health & Awareness & Guidance
(SHAG) Week. Posters and leaﬂets distributed around campus. Media releases,
radio broadcasts, email alerts and newspaper articles publicises the intervention.
Intervention steering group (student health units and student unions). Use of peer
volunteers. Testing packs distributed around campus, especially in male and female toilets.
van Bergen et al. (2010)30
van den Broek et al. (2010)
Netherlands31
1. Target behaviour: Home urine test (males), home vaginal swab (females)
2. Customer Orientation: formative research and pilot data
Insight: identiﬁed and addressed barriers
3. Theory: N/A
4. Insight: N/A
5. Exchange: used home based test to reduce barriers
6. Competition: N/A
7. Segmentation: N/A
8. Methods Mix: Invitation letter (population register – invited to participate if are or
have been sexually active) promoting the website and a personal code; Secure Website
(information; ‘risk assessment score’; place to request home sampling kit; facility
to notify partners anonymously; Home Chlamydia test (urine or vaginal swab); Testing
in three regional accredited laboratories; Advice and referral letter for treatment
(self and current partner); Positive test recipient receive a test package 6 months
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All except one32 addressed the monetary cost
involved in screening by providing free tests/
kits. Mitigating other costs (e.g. time, eﬀort)
was addressed more comprehensively in some
interventions than others. For example, to
promote the uptake of home CT screening
behaviours, some interventions distributed kits
directly by mail to participants,41,45 while
others necessitated time and eﬀort to request
a kit via a mailed form45 or online
requests28–30,40,46,47 or provided tests in more
accessible locations.32
Interventions also addressed barriers to spec-
imen delivery to a laboratory by mail32–34 or
by onsite processing.37 Access barriers to
receiving results were addressed by sending
results via use of phone, SMS, email or post
and access to treatment also by post44. Other
barriers of access addressed included transport,
health insurance and conﬁdentiality.40 It is also
likely that many of these home-based interven-
tions also overcame some of the embarrass-
ment or stigma associated with asking for and
receiving a CT test – although this was not
reported against in any of the studies.
In terms of oﬀering incentives or beneﬁts,
most interventions highlight the beneﬁts of
screening and treatment, for example a sense
of relief and peace of mind by taking a test.39
Others interventions oﬀered, prizes (from $10-
$80) issued randomly and treatment services
oﬀered at times and locations convenient to
students,37 cold drinks, lollipops, a prize draw
for MP3 player, CD vouchers,44 access to free,
anonymous, easy to access and private screen-
ing process,39 soft drink, water and class leave
passes36 and volunteers oﬀered monetary
vouchers as incentives.36,39
Competition
All of the interventions sought to enhance the
exchange for the target audience by addressing
the barriers of access to screening in the pri-
mary care setting by utilizing non-clinical set-
tings (e.g. music festivals or pharmacies), or
via establishing a presence in an online envi-
ronment. For example, use of home-based kits
addressed both internal barriers (e.g. fear of
pelvic examination, embarrassment) and exter-
nal barriers (time to visit clinic, costs, paren-
tal involvement).28,29 Alicea-Alvarez et al.36
directly addressed the competing behaviour of
‘attending class’ by oﬀering ‘passes’ to attend
the school clinic. Wilkins and Mak27 also used
reminders in recognition that participants’ may
be distracted or forget about screening.
Segmentation
With the exception of four interventions, two
of which were set in pharmacies,27,32,33,43,47 all
Table 3. Continued
Study Coding against benchmark criteria
after ﬁrst test
Repeated invitation letter (1 year) – no results available yet on value of repeat invitations
Wilkins and Mak (2007)
Australia27
1. Target behaviour: Clinic urine test (males), clinic vaginal swab (females)
2. Customer Orientation: N/A
3. Theory: N/A
4. Insight: Focus groups – not described
5. Exchange: use of reminders to overcome barriers
6. Competition: N/A
7. Segmentation: GPs and community
8. Methods Mix: Mass and narrow case media (TV, radio, posters (pubs/clubs
hotels/uni/tafe/ magazines and print ads)– directing people to Interactive website
(Q&A); SMS (to people registered to receive smoking SMS/for this project);
GPs – Chlamydia Information Kits; Posters for waiting rooms
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interventions deﬁned speciﬁc target audiences
for their programme. Eight were deﬁned on the
basis of age,26,27,30,37,41,44,46 one on gender,45
four on age and gender29,34–36,40 and one tar-
geting attendees at a University.38 Geographic
segments were also targeted including schools
within disadvantaged or rural communities in
two interventions,36,37,39 at a regional level41 and
another at a state level.26 Finally, one interven-
tion targeted attendees at a music festival.44
Whilst tailoring of the programmes to meet the
speciﬁc needs of these segments may have
occurred in the design of the programmes.
Unfortunately, if or how this was done was not
made explicit within the reporting of most of
the articles. Three exceptions included Alicea-
Alvarez et al.36 who discussed the development
of gender-speciﬁc messages and materials for
adolescent girls in a rural setting, and two other
interventions, which reported tailoring resources
for GPs and community.26,27
Methods mix
Social marketing interventions do not rely
solely on education, but utilize the breadth of
the marketing mix: product, price, place and
promotion.
Product
‘Product’ refers to the desired behaviour (actual
product) and the set of beneﬁts associated with
the desired behaviour (core product).18 In this
study, the use of a CT screening test is the
desired behaviour (actual product), whilst the
beneﬁts that people accrue from screening use
such as conﬁdential free treatment, avoiding
infertility caused by Chlamydia, or not infecting
future partners are core products. The mostly
commonly promoted actual product was home-
based urine test kit,32,35,40,43,44,47 and urine tests
which could be taken in ‘alternative’ set-
tings.36,37,39,42 Vaginal swabs were less fre-
quently promoted both for home use28,29,41–43
and in one alternative on-campus setting.38 Only
one intervention provided users a choice or
vaginal or urine testing.30,31 Two interventions
also promoted screening at community health
clinics and/or with a GP, but did not specify the
type of test.26,27
Augmented products are the features that
encourage uptake of an actual product or ser-
vice. In this case, augmented products are those
that support people in their use of the promoted
CT screening test. In the interventions products
used to support the use CT testing included
interactive websites, phone information lines,
information resources (on screen and printable),
referral support (print outs or phone support)
and partner notiﬁcation services (online).
Supportive online features included facilities
to assist participants to calculate risk scores,
‘Question and Answer’ educational information,
results notiﬁcation services45,47 and an email
facility for anonymous partner notiﬁcation.30,31
Phone services oﬀered with some interventions
included a recorded information line, staﬀ sup-
ported information lines,32 counselling services
and results notiﬁcation services.32,33,39,40,44
These services oﬀered information (and/or sup-
port) at various points including prior to screen-
ing, to communicate results and to support
access to treatment or discuss results. Interven-
tions in alternative non-medical clinics within
educational settings may have also provided
trained personnel as an augmented service to
support the uptake of screening in the target
audiences,36–39 although this was not clearly
described.
Price
Price was addressed within the interventions
in the following ways: the provision of a free
test kit, or free treatment (addressing mone-
tary costs), and providing testing in a non-
clinical home or educational setting; the use
of direct mail for distribution of tests kits,
online, phone or post results notiﬁcation,
phone information, support and advice lines;
post-treatment support including partner noti-
ﬁcation services (all addressing psychological
and time costs).
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Place
In regards to the ‘where’ of CT service use, the
‘actual product’ section of this paper has
detailed how the ‘where’ component of screen-
ing (home based vs. clinic based screening) can
inﬂuence uptake of screening behaviours.
Communication channels
The interventions used a variety of strategies
including brochures, leaﬂets, posters and cards
in 14 interventions.26–35,37,40,41,45,46 Four of these
distributed promotions via direct mail,30,31,41,45,46
seven via mass or narrow cast media (e.g. radio,
TV, email alerts and video ads at sporting
grounds).26–29,39,40,46,47 In-class presentations
were also utilized in high-school settings36,37 and
at youth groups and public health clinics.42
Websites were utilized in eight interventions,27–
31,40,42,43,47 interpersonal channels in pharmacy
settings32,33 and at the music festival.44
Promotion
Not all the interventions speciﬁed promotional
messages that were utilized as part of their pro-
gramme. Of those with associated websites
mentioned in publications describing included
interventions, the following messages were
identiﬁed. Firstly, “I want the kit’40 focusing
on how participants could obtain free
Chlamydia testing. Another, “Most people
don’t have a clue” focused on lack of knowl-
edge about Chlamydia.27 This intervention also
used rotating comic book style images with slo-
gans including “Could my partner have it?’,
‘Could I be infertile?’, ‘My package looks good
but could I have it?’ and ‘Could I have it
again?’ to engage people at risk but potentially
unaware. This intervention also used radio but-
tons highlighting where to get Chlamydia
information and especially ‘Free testing’.
The ‘Get the Facts’ Website43 focused on
information including signs and symptoms, risk
factors and the need to get tested and treated.
Vaughan et al.,39 also promoted Chlamydia
screening during the Annual Sexual Health and
Awareness and Guidance (SHAG) Week.
However, no speciﬁc Chlamydia campaign
materials could be identiﬁed via the website.
Discussion
To our knowledge, this is the ﬁrst systematic
review of community-based Chlamydia screen-
ing interventions in a range of non-clinical
settings, and the ﬁrst to utilize the social mar-
keting benchmark criteria as a framework to
evaluate the nature, strategies and outcomes of
interventions against behavioural goals. This
systematic review identiﬁed 20 articles examin-
ing the eﬀectiveness of interventions to engage
young adults in community-based (non-
medical) settings to participate in CT screening.
Whilst the overall quality of evidence available
was low (including variations in study design,
numbers of participants and a variation in the
methods utilized to collect evaluation data), a
descriptive systematic review of current
approaches to promoting screening behaviours
in community settings remains useful, generat-
ing lessons to be drawn to inform future
research and intervention designs.
Overall, the results in regard to the potential
eﬀectiveness of community-based interventions
to promote CT screening in young people are
promising. Across all of the interventions, 15
reported achieving high proportional screening
rates26,27,29,30,32,34,41,42,44 when compared to
rates within primary care settings in countries
such as Australia. This suggests that screening
promoted in community-based settings may
overcome some of the barriers to screening per-
formed in health and medical clinics. All inter-
ventions that oﬀered an alternative ‘clinic’ in
educational settings resulted in higher rates of
screening than is typical in the primary care
setting, whilst those promoting home-based
tests produced mixed results with some higher
and some lower rates than primary care. This
suggests there may still be value to the target
audience in face-to-face, supported screening
and that overcoming some of the time, access
and psychological barriers of traditional medi-
cal clinics may be eﬀective in increasing partici-
pation in screening.
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Four interventions also achieved a higher
positivity rate than is currently observed in sex-
ual health clinics.48 Three of these four inter-
ventions included a formal risk assessment for
participants as part of the strategy to promote
testing in higher risk groups,27,40,43 suggesting
that the incorporation of such a programme
feature may be important to reach higher risk
segments of the population.
In relation to promoting screening that leads
to treatment of Chlamydia, only four included
interventions reported the proportion of
those who accessed treatment following a posi-
tive test result (ranging between 47.1 and
91%).32,35,39,43 Therefore, the eﬀectiveness of
community-based screening as a pathway to
treatment is less certain. This is important
because an analysis of the intervention strategies
shows a tendency of community interventions to
only address the ‘cost’ of screening by focusing
on improving access to ‘a kit’ and also to results.
However, the barriers (time and psychological)
that exist for young people to presenting to a
medical clinic for treatment remain and were
addressed in only one of the interventions,
which also provided treatment by post.
Overall, the systematic review suggests that
those programmes in a community setting that
incorporated a greater range of strategies con-
sistent with social marketing principles were
likely to achieve more positive results (even if
they were not planned with, or self-identiﬁed
as using the social marketing framework). This
demonstrates the utility and potential of social
marketing in the development of community-
based CT interventions. Furthermore, the
social marketing benchmark criteria present a
useful evaluation tool.
The systematic review also identiﬁed that
interventions did not comprehensively utilize
social marketing as a strategic framework. This
is not surprising given that most included inter-
ventions were not self-identiﬁed as social mar-
keting. Given its eﬀectiveness as a behaviour
change approach, the analysis presented here
generates useful insight that can inform the
development and implementation of future CT
screening interventions. A key ﬁnding was that
included interventions often failed to use or
failed to report use of formative research.
Therefore, CT screening interventions should
place a greater emphasis on formative research
to understand the attitudinal and behavioural
segments within the target audience. This
should improve insight and opportunities for
segmenting and tailoring interventions. Seg-
mentation of the target audiences in the major-
ity of the interventions was deﬁned on the
basis of age (range 14–29) and geographic
region; only ﬁve speciﬁed a gender target
group. Whilst tailoring of the programmes to
meet the speciﬁc needs of these segmentation
may have occurred in the design of the pro-
grammes – unfortunately, how this was done
was not made explicit within the reporting of
included studies. There was also no evidence of
targeting of interventions to minority ethnic
groups or other more vulnerable populations
other than on the basis of geographic
region.36,37 Given the known diﬀerences in atti-
tudes, stigma and health behaviours between
genders and cultures, this is surprising, high-
lighting the need for consideration of pro-
grammes targeted and towards these market
segments. Interestingly, two interventions also
targeted on the basis of other behaviours (e.g.
attendance at a University health clinic and pur-
chase of oral contraceptives). Results from these
two studies were both mixed, suggesting the
need for further research to explore the value of
‘coupling’ CT screening with other behaviours.
Few existing CT screening interventions cur-
rently reported using behavioural theory in
their design and implementation. Given the
eﬃcacy of use of theory to inform behaviour
change programmes in other domains, future
CT screening interventions should be theoreti-
cally framed. Post-intervention process analysis
of ‘why’ people did or did not participate
would also oﬀer insight.
Further research on young people from cul-
turally and linguistically diverse also appears
warranted. Finally, few current interventions
adequately address the competition to the
desired behaviour. Research to identify why a
particular target segments do not present for
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screening and helping to identify competitive
behaviours and inﬂuences should be a compo-
nent of future CT screening programmes.
Conclusion
Whilst the quality of evidence remains low for
current approaches, a systematic review of
community-based interventions to promote
CT screening in young people <30 years
suggests the potential utility of strategic
community-based social marketing interven-
tions across a range of settings to promote
screening at higher rates than currently exist
in primary care for this target group. The use
of clinics in educational settings (which over-
come the barriers of time and cost of visiting
a medical clinic) suggests the value of face-to-
face support and interaction for some young
people. The use of risk assessment tools also
shows promise in community settings to
increase positivity rates. Evaluation of pro-
gramme strategies according to social market-
ing benchmark criteria highlighted that whilst
few comprehensively incorporated all social
marketing principles those that did incorpo-
rate, a greater range of strategies were likely
to be eﬀective. Given its eﬀectiveness as a stra-
tegic approach to promote health behaviour
change, the use of social marketing to develop
future CT screening interventions holds poten-
tial to improve outcomes. Formative research
to increase insight, facilitate engagement and
enable segmentation and tailoring of screening
interventions may also improve outcomes.
Finally, robust evaluation is required to pro-
vide evidence of the eﬃcacy of CT social mar-
keting interventions and generate further
insight on eﬀective strategies for engaging
young people.
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